Tag results:
B cells
Human Immunology News
Peripheral Immunophenotyping of AITD Subjects Reveals Alterations in Immune Cells in Pediatric vs Adult-Onset AITD
[iScience] Scientists performed phenotypic and functional characterization of peripheral blood immune cells from pediatric and adult-onset autoimmune thyroid disease (AITD) patients and age-matched controls using mass cytometry.
Immunology of Infectious Disease News
HLA-Aā02:01 Restricted T Cell Receptors against the Highly Conserved SARS-CoV-2 Polymerase Cross-React with Human Coronaviruses
[Cell Reports] Scientists identified SARS-CoV-2 RNA-dependent RNA-polymerase as highly conserved likely due to its critical role in the virus life cycle.
ESC & iPSC News
Regeneration of Immunocompetent B Lymphopoiesis from Pluripotent Stem Cells Guided by Transcription Factors
[Cellular & Molecular Immunology] Researchers unveiled the guiding role of three essential factors, Lhx2, Hoxa9, and Runx1, the simultaneous expression of which preferentially drove B lineage fate commitment and in vivo B lymphopoiesis using PSCs as a cell source.
Pancreatic Cell News
Smoothened (SMO) Regulates Insulin-Like Growth Factor 1 Receptor (IGF1R) Levels and Protein Kinase B (AKT) Localization and Signaling
[Laboratory Investigation] Investigators provided evidence that elevated levels of human SMO showed a strong correlation with elevated levels of insulin-like growth factor 1 receptor and reduced survival in diffuse large B-cell lymphoma.
Cell Therapy News
Neurocognitive and Hypokinetic Movement Disorder with Features of Parkinsonism after BCMA-Targeting CAR-T Cell Therapy
[Nature Medicine] Public transcriptomic datasets confirmed B cell maturation antigen (BCMA) RNA expression in the caudate of normal human brains, suggesting that this may be an on-target effect of anti-BCMA therapy.
Cell Therapy News
Multiple Site Place-of-Care Manufactured Anti-CD19 CAR-T Cells Induce High Remission Rates in B Cell Malignancy Patients
[Nature Communications] The authors developed an anti-CD19 CAR comprised of the 4-1BB co-stimulatory and TNFRSF19 transmembrane domains, showing anti-tumor efficacy in an in vivo xenograft lymphoma model.